1Liu J, Kjaergard LL, Gluud C. Misuse ofrandomization:a review of Chinese randomized trials of herbal medicines for chronic hepatitis B. Am J Chin Med,2002,30( 1 ) :173-176 被引量：1
2Sim I, Cummings SR. A new framework for describing and quantifying the gap between proof and practice [J]. Med Care, 2003; 41(8): 874-881 被引量：1
3Young JM, Hollands MJ, Ward J, Holman CD. Role for opinion leaders in promoting evidence-based surgery [J]. Arch Surg, 2003; 138(7): 785-791 被引量：1
4Schulz KF,Chalmers I,Grimes DA,et al.Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology joumals.JAMA,1994; 272:125-128. 被引量：1
5Schulz KF,Chalmers I,Hayes R J,et al.Empirical evidence of bias dimensions of methodologic quality associated with estimates of treatment effect in controlled clinical trials.JAMA,1995; 273:408 -412. 被引量：1
6Pocok S J,Hughes MD,Lee Rj.Statistical problems in the reporting of clinical trials.N Engl J Med,1987; 317:426-432. 被引量：1
7David Moher,Kenneth F.Schulz,Douglas G.Altman,for the CONSORT Group.The CONSORT Statement:Revised Recommendations for Improving the Quality of Reports of ParallelGroup Randomized Trials Ann Intern Med.2001; 134:657-662. 被引量：1
8Moher D,Jones A,Lepage L,for the CONSORT Group.Use of the CONSORT statement and quality of reports of randomized trials:a comparative before and after evaluaton? JAMA,2001; 285(15):1992-1995. 被引量：1
9Tang JL,Zhan SY,Ernst E.Review of randomised controlled trials of traditional Chinese medicine.BMJ,1999; 319(7 203):160-161. 被引量：1
10Fehcher R H, et al. Clinical Epidermiology- The Essentials.Williams & Wilkins. Third edition. 1996:2, 249. 被引量：1
